全文获取类型
收费全文 | 8033篇 |
免费 | 566篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 136篇 |
儿科学 | 303篇 |
妇产科学 | 188篇 |
基础医学 | 1110篇 |
口腔科学 | 126篇 |
临床医学 | 720篇 |
内科学 | 1465篇 |
皮肤病学 | 97篇 |
神经病学 | 900篇 |
特种医学 | 222篇 |
外科学 | 1131篇 |
综合类 | 107篇 |
一般理论 | 15篇 |
预防医学 | 576篇 |
眼科学 | 209篇 |
药学 | 572篇 |
中国医学 | 10篇 |
肿瘤学 | 743篇 |
出版年
2023年 | 89篇 |
2022年 | 180篇 |
2021年 | 266篇 |
2020年 | 188篇 |
2019年 | 212篇 |
2018年 | 264篇 |
2017年 | 221篇 |
2016年 | 242篇 |
2015年 | 255篇 |
2014年 | 327篇 |
2013年 | 422篇 |
2012年 | 626篇 |
2011年 | 537篇 |
2010年 | 352篇 |
2009年 | 262篇 |
2008年 | 399篇 |
2007年 | 441篇 |
2006年 | 389篇 |
2005年 | 351篇 |
2004年 | 342篇 |
2003年 | 323篇 |
2002年 | 326篇 |
2001年 | 131篇 |
2000年 | 109篇 |
1999年 | 133篇 |
1998年 | 63篇 |
1997年 | 58篇 |
1996年 | 44篇 |
1995年 | 38篇 |
1994年 | 29篇 |
1993年 | 29篇 |
1992年 | 71篇 |
1991年 | 63篇 |
1990年 | 55篇 |
1989年 | 68篇 |
1988年 | 51篇 |
1987年 | 52篇 |
1986年 | 50篇 |
1985年 | 58篇 |
1984年 | 42篇 |
1983年 | 35篇 |
1982年 | 34篇 |
1981年 | 28篇 |
1979年 | 48篇 |
1978年 | 26篇 |
1977年 | 25篇 |
1976年 | 25篇 |
1975年 | 22篇 |
1973年 | 27篇 |
1972年 | 27篇 |
排序方式: 共有8630条查询结果,搜索用时 15 毫秒
91.
92.
Dahniya MH Hanna RM Grexa E Cherian MJ Niazy MN Badr S Ibrahim F al-Othman AN 《Australasian radiology》1999,43(4):444-447
Most intra-abdominal and other types of fluid collections are now successfully drained percutaneously under image guidance. The utility of percutaneous drainage of tuberculous abscesses, especially those associated with osseous changes, is, however, less well established. Six patients with tuberculous iliopsoas abscesses were successfully managed by percutaneous drainage combined with antituberculous therapy. The abscesses were bilateral in one patient and unilateral in the other five. Drainage was by needle aspiration under ultrasound (US) guidance in one patient, and by catheter under CT guidance in the other patients. Three patients had associated osseous changes. There were no procedural complications. Tuberculous iliopsoas abscess can be successfully treated by percutaneous drainage and appropriate antituberculous therapy. 相似文献
93.
Nicole E. Sharp Wendy J. Svetanoff Amita Desai Hanna Alemayehu Maneesha U. Raghavan Susan W. Sharp James C. Brown Douglas C. Rivard Shawn D. St. Peter George W. Holcomb III 《The Journal of surgical research》2014
Background
We have previously reported that children receive significantly less radiation exposure after abdominal and/or pelvis computed tomography (CT) scanning for acute appendicitis when performed at our children's hospital (CH) rather than at outside hospitals (OH). In this study, we compare the amount of radiation children receive from head CTs for trauma done at OH versus those at our CH.Methods
A retrospective chart review was performed on all children transferred to our hospital after receiving a head CT for trauma at an OH between July 2012 and December 2012. These children were then blindly case matched based on date, age, and gender to children at our CH.Results
There were 50 children who underwent head CT scans for trauma at 28 OH. There were 21 females and 29 males in each group. Average age was 7.01 ± 0.5 y at the OH and 7.14 ± 6.07 at our CH (P = 0.92). Average weight was 30.81 ± 4.69 kg at the OH and 32.69 ± 27.21 kg at our CH (P = 0.81). Radiation measures included dose length product (671.21 ± 22.6 mGycm at OH versus 786.28 ± 246.3 mGycm at CH, P = 0.11) and CT dose index (53.4 ± 2.26 mGy at OH versus 49.2 ± 12.94 mGy at CH, P = 0.56).Conclusions
There is no significant difference between radiation exposure secondary to head CTs for traumatic injuries performed at OH and those at a dedicated CH. 相似文献94.
Tomasz Skowerski Katarzyna Nabrdalik Hanna Kwiendacz Maciej Pajak Katarzyna Mizia-Stec Zbigniew Gasior Janusz Gumprecht 《Archives of Medical Science》2022,18(3):624
IntroductionAngiopoietin-2 (Ang-2) is a novel marker of coronary artery disease (CAD) and diabetes (DM). The aim was to evaluate Ang-2 as a potential new biomarker of non-ST elevation myocardial infarction (NSTEMI) in patients with or without type 2 DM (T2DM).Material and methodsThis was a multi-center, prospective study that included 138 (males: 91/66%) consecutive patients hospitalized due to NSTEMI, T2DM, or different cardiac disorders. The subjects were divided into four study groups: group A: 28 patients with NSTEMI and T2DM; group B: 47 patients with NSTEMI without T2DM; group C: 31 patients with T2DM, without a history of CAD; group D: 32 patients as a control group. Patients with NSTEMI underwent urgent coronarography. Clinical characteristics including biomarkers (hs-CRP, hsTnT, NT-proBNP, VEGF, HbA1c), SYNTAX SCORE, type of intervention (PCI vs. CABG), and number of implanted stents were taken into account in the analysis.ResultsSerum Ang-2 concentrations were significantly higher in patients with NSTEMI (group A: 1769 pg/ml; group B: 1757 pg/ml) and patients with T2DM (group C: 1993 pg/ml) as compared to the patients without CAD and without T2DM (group D: 866.8 pg/ml; p < 0.05). The prognostic accuracy of Ang-2 in NSTEMI diagnosis was determined with the area under the ROC curve (area under curve (AUC) = 0.63).ConclusionsAngiopoietin-2 serum concentration is elevated in the presence of NSTEMI in patients with and without T2DM and does not correspond to the degree of myocardial injury and hemodynamic status. Ang-2 remains elevated also in patients with T2DM without a history of CAD. 相似文献
95.
Olumide B. Gbolahan Bert H. ONeil Autumn J. McRee Hanna K. Sanoff John K. Fallon Philip C. Smith Anastasia Ivanova Dominic T. Moore Julie Dumond Gary N. Asher 《CTS Clinical and Translational Science》2022,15(5):1304
Curcumin inhibits UDP‐glucuronyltransferases, a primary metabolic pathway for cancer chemotherapeutic agents like irinotecan. Concurrent administration of both agents may exacerbate irinotecan toxicity. We conducted this phase I study to determine the safety of concurrent curcumin and irinotecan administration. Ten participants with advanced solid tumors received one of four doses (1, 2, 3, and 4 g) of a curcumin phosphatidylcholine complex (PC) orally daily, and 200 mg/m2 of i.v. infusion irinotecan on days 1 and 15 of a 28‐day cycle, to determine the maximum tolerated dose (MTD) of PC. Thirteen participants received 4 g of PC (MTD) to assess the effect on the pharmacokinetic (PK) properties of irinotecan and its metabolites, SN‐38 and SN‐38G. Irinotecan, SN‐38, and SN‐38G exposure equivalence with and without curcumin was assessed using area under the plasma concentration‐time curves from 0 to 6 h (AUC0‐6h). Safety assessments and disease responses were also evaluated. The combination of irinotecan and PC was well‐tolerated. Because there was no dose limiting toxicity, the maximum dose administered (4 g) was defined as the recommended phase II dose of PC. PC did not significantly alter the plasma exposure and other PK properties of irinotecan and its metabolites. There was no apparent increase in the incidence of irinotecan‐associated toxicities. The objective response rate was 3/19 (22%, 95% confidence interval [CI]: 5–39%), median progression free survival and overall survival (n = 23) were 4 months (95% CI: 2.9–8.9 months) and 8.4 months (95% CI: 3.7 – not evaluable [NE]), respectively. Future studies are required to evaluate the efficacy of this combination. Study Highlights
- WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
- WHAT QUESTION DID THIS STUDY ADDRESS?
- WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
- HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?
96.
97.
98.
Hanna Zirath Anna Frenzel Ganna Oliynyk Lova Segerstr?m Ulrica K. Westermark Karin Larsson Matilda Munksgaard Persson Kjell Hultenby Janne Lehti? Christer Einvik Sven P?hlman Per Kogner Per-Johan Jakobsson Marie Arsenian Henriksson 《Proceedings of the National Academy of Sciences of the United States of America》2013,110(25):10258-10263
The MYC genes are the most frequently activated oncogenes in human tumors and are hence attractive therapeutic targets. MYCN amplification leads to poor clinical outcome in childhood neuroblastoma, yet strategies to modulate the function of MYCN do not exist. Here we show that 10058-F4, a characterized c-MYC/Max inhibitor, also targets the MYCN/Max interaction, leading to cell cycle arrest, apoptosis, and neuronal differentiation in MYCN-amplified neuroblastoma cells and to increased survival of MYCN transgenic mice. We also report the discovery that inhibition of MYC is accompanied by accumulation of intracellular lipid droplets in tumor cells as a direct consequence of mitochondrial dysfunction. This study expands on the current knowledge of how MYC proteins control the metabolic reprogramming of cancer cells, especially highlighting lipid metabolism and the respiratory chain as important pathways involved in neuroblastoma pathogenesis. Together our data support direct MYC inhibition as a promising strategy for the treatment of MYC-driven tumors. 相似文献
99.
100.
Katarzyna Winiarska Jolanta M. Dzik Mateusz Labudda Dorota Focht Bartosz Sierakowski Aleksandra Owczarek Lukasz Komorowski Wojciech Bielecki 《Journal of pineal research》2016,60(1):109-117
Excessive activity of NADPH oxidase (Nox) is considered to be of importance for the progress of diabetic nephropathy. The aim of the study was to elucidate the effect of melatonin, known for its nephroprotective properties, on Nox activity under diabetic conditions. The experiments were performed on three groups of animals: (i) untreated lean (?/+) Zucker diabetic fatty (ZDF) rats; (ii) untreated obese diabetic (fa/fa) ZDF rats; and (iii) ZDF fa/fa rats treated with melatonin (20 mg/L) in drinking water. Urinary albumin excretion was measured weekly. After 4 wk of the treatment, the following parameters were determined in kidney cortex: Nox activity, expression of subunits of the enzyme, their phosphorylation and subcellular distribution. Histological studies were also performed. Compared to ?/+ controls, ZDF fa/fa rats exhibited increased renal Nox activity, augmented expression of Nox4 and p47phox subunits, elevated level of p47phox phosphorylation, and enlarged phospho‐p47phox and p67phox content in membrane. Melatonin administration to ZDF fa/fa rats resulted in the improvement of renal functions, as manifested by considerable attenuation of albuminuria and some amelioration of structural abnormalities. The treatment turned out to nearly normalize Nox activity, which was accompanied by considerably lowered expression and diminished membrane distribution of regulatory subunits, that is, phospho‐p47phox and p67phox. Thus, it is concluded that: (i) melatonin beneficial action against diabetic nephropathy involves attenuation of the excessive activity of Nox; and (ii) the mechanism of melatonin inhibitory effect on Nox is based on the mitigation of expression and membrane translocation of its regulatory subunits. 相似文献